Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Contrast Media × Dermatologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5 Sarcoma 1 Gastrointestinal 1 Dermatologic 1

Conditions

Melanoma 1 Lung Neoplasms 1

Interventions

pembrolizumab 22 Nivolumab 16 Magnetic Resonance Spectroscopy 11 Specimen Handling 9 Cyclophosphamide 9 Radiosurgery 7 Drug Therapy 6 Radiotherapy 5 Paclitaxel 5 Ipilimumab 5 fludarabine 4 Biopsy 4 trametinib 3 sargramostim 3 Trastuzumab 3 Taxes 3 Pemetrexed 3 Metformin 3 Interleukin-2 3 Immunoglobulin G 3 Gemcitabine 3 Carboplatin 3 Bevacizumab 3 tremelimumab 2 temsirolimus 2 poly ICLC 2 pertuzumab 2 osimertinib 2 motexafin gadolinium 2 epacadostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡